-
AM-Pharma enrols first Covid-19 patients in Phase III clinical trial
pharmaceutical-technology
January 11, 2021
AM-Pharma has announced the enrolment of first participants in an exploratory cohort in Phase III REVIVAL pivotal trial of its human recombinant alkaline phosphatase (AP) for treating patients with Covid-19 and sepsis-associated acute kidney injury.
-
Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants
pharmaceutical-technology
January 11, 2021
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2, the virus that causes Covid-19, that have emerged in the UK and South Africa.
-
World awaits India’s vaccines, watching how it handles globe’s biggest vaccination drive: PM Modi
expresspharma
January 11, 2021
He said the country is among the nations with the lowest fatality rate and the highest recovery rate.
-
Roll-out of COVID-19 vaccination in India to begin on January 16, 2021
expresspharma
January 11, 2021
Priority will be given to estimated three crore healthcare workers and the frontline workers, followed by those above 50 years of age and the under-50 population groups with co-morbidities.
-
Humanigen, EVERSANA to partner for launch, commercialisation of Lenzilumab for COVID-19 treatment
expresspharma
January 11, 2021
Lenzilumab, a monoclonal antibody, is designed to prevent and treat cytokine storm, a complication considered to be a leading cause of COVID-19 death.
-
Tocilizumab and sarilumab reduce COVID-19 patient mortality by 8.5 percent, data shows
europeanpharmaceuticalreview
January 08, 2021
IL-6 receptor antagonists tocilizumab and sarilumab have a significant impact on COVID-19 patient mortality, a study has shown.
-
ForaCare Suisse AG Releases Rapid COVID-19 Antigen Test
prnewswire
January 08, 2021
ForaCare Suisse AG announced the release of its antigen test, FORA COVID-19 Antigen Rapid Test, that provides fast, accurate and easy-to-interpret test results.
-
The Health Research Authority launches fast-track service for non-COVID-19 research
pharmatimes
January 08, 2021
The Health Research Authority (HRA) has launched a new service offered to pharmaceutical companies and research organisations which will accelerate the ethics review stage of clinical trials approval.
-
University of Glasgow to establish Covid-19 drug screening hub
pharmaceutical-technology
January 08, 2021
The MRC-University of Glasgow Centre for Virus Research (CVR) is set to establish a Covid-19 drug screening and resistance hub in Scotland.
-
MilliporeSigma Acquires AmpTec
contractpharma
January 08, 2021
?MilliporeSigma has announced the acquisition of AmpTec, a Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO).